Literature DB >> 21644994

Dopamine release mediated by the dopamine transporter, facts and consequences.

Vincent Leviel1.   

Abstract

Spontaneous and/or stimulated neural activity of the nigrostriatal dopamine (DA) pathway makes amines run out from the neurons. This DA dynamic follows a rather complex path, running in or out the terminals, and flushing or diffusing into the extracellular space. The location of this leakage is not limited to the axon terminals; it also occurs from the cell bodies and dendrites. This molecular release mechanism was, for a long time, considered as being produced, in part, by the exocytosis of previously stored vesicles. The DA carrier protein (DAT, DA transporter) embedded in the DA cell membrane is known to clear previously released amines through an inward DA influx. The DAT also appears to be an active vector of amine release. Particular local conditions and the presence of numerous psychostimulant substances are able to trigger an outward efflux of DA through the DAT. This process, delivering slowly large amounts of amine could play a major regulatory role in extracellular DA homeostasis.
© 2011 The Author. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644994     DOI: 10.1111/j.1471-4159.2011.07335.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

Review 3.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

4.  Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Authors:  Lydia M M Vermeer; Virginia R Florang; Jonathan A Doorn
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

5.  Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.

Authors:  Marcelo Q Hoexter; Gustavo Fadel; André C Felício; Mariana B Calzavara; Ilza R Batista; Marilia A Reis; Ming C Shih; Roger K Pitman; Sérgio B Andreoli; Marcelo F Mello; Jair J Mari; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2012-06-15       Impact factor: 4.530

6.  The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

Authors:  Chelsea T Tiernan; Ethan A Edwin; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2013-02-19       Impact factor: 4.849

7.  Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.

Authors:  Kaustuv Saha; Danielle Sambo; Ben D Richardson; Landon M Lin; Brittany Butler; Laura Villarroel; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

8.  The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells.

Authors:  Jerome A Roth; Zhezheng Li; Swetha Sridhar; Habibeh Khoshbouei
Journal:  Neurotoxicology       Date:  2013-01-11       Impact factor: 4.294

9.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

Review 10.  Mechanisms of dopamine transporter regulation in normal and disease states.

Authors:  Roxanne A Vaughan; James D Foster
Journal:  Trends Pharmacol Sci       Date:  2013-08-20       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.